Health-related quality of life measurement strategy for solid rare cancers - Strategia per la misurazione della qualità di vita correlata alla salute nei tumori solidi rari

Title

Code

QUALITY-SARC

Type

Osservazionale

Start Year

2023

Status

In Corso

Principal Investigator

051-6366452

eric.staals@ior.it

Staals Eric L., MD

3rd Orthopaedic and Traumatologic Clinic prevalently Oncologic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica III a prevalente indirizzo Oncologico

Director

Donati Davide Maria, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. QUALITY-SARC

Tuesday 5 September 2023, 11:17

PG0012725_2023_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Health-related quality of life measurement strategy for solid rare cancers - Strategia per la misurazione della qualità di vita correlata alla salute nei tumori solidi rari

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Health-related quality of life measurement strategy for solid rare cancers - Strategia per la misurazione della qualità di vita correlata alla salute nei tumori solidi rari

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in